These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29194687)
1. Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models. Fiandalo MV; Wilton JH; Mantione KM; Wrzosek C; Attwood KM; Wu Y; Mohler JL Prostate; 2018 Feb; 78(3):213-221. PubMed ID: 29194687 [TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation and expression of AR/PSA by herbal supplement Equiguard in LNCaP cells cultured in androgen-proficient FBS and androgen-deficient charcoal-stripped FBS is correlated with increased serine-15 phosphorylation of the tumor suppressor gene p53. Lu X; Guo J; Hsieh TC; Wu JM Anticancer Res; 2003; 23(3B):2489-98. PubMed ID: 12894532 [TBL] [Abstract][Full Text] [Related]
4. Proteomic Analysis of Charcoal-Stripped Fetal Bovine Serum Reveals Changes in the Insulin-like Growth Factor Signaling Pathway. Tu C; Fiandalo MV; Pop E; Stocking JJ; Azabdaftari G; Li J; Wei H; Ma D; Qu J; Mohler JL; Tang L; Wu Y J Proteome Res; 2018 Sep; 17(9):2963-2977. PubMed ID: 30014700 [TBL] [Abstract][Full Text] [Related]
5. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line. Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094 [TBL] [Abstract][Full Text] [Related]
6. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223 [TBL] [Abstract][Full Text] [Related]
7. Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum. Tamae D; Byrns M; Marck B; Mostaghel EA; Nelson PS; Lange P; Lin D; Taplin ME; Balk S; Ellis W; True L; Vessella R; Montgomery B; Blair IA; Penning TM J Steroid Biochem Mol Biol; 2013 Nov; 138():281-9. PubMed ID: 23851165 [TBL] [Abstract][Full Text] [Related]
8. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701 [TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Zhao XY; Ly LH; Peehl DM; Feldman D Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780 [TBL] [Abstract][Full Text] [Related]
10. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells. Lee SO; Pinder E; Chun JY; Lou W; Sun M; Gao AC Prostate; 2008 Jan; 68(1):85-91. PubMed ID: 18008330 [TBL] [Abstract][Full Text] [Related]
12. Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line. Kirschenbaum A; Ren M; Levine AC Steroids; 1993 Sep; 58(9):439-44. PubMed ID: 8236330 [TBL] [Abstract][Full Text] [Related]
13. Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone. Sedelaar JP; Isaacs JT Prostate; 2009 Dec; 69(16):1724-9. PubMed ID: 19676093 [TBL] [Abstract][Full Text] [Related]
14. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Lee C; Sutkowski DM; Sensibar JA; Zelner D; Kim I; Amsel I; Shaw N; Prins GS; Kozlowski JM Endocrinology; 1995 Feb; 136(2):796-803. PubMed ID: 7530653 [TBL] [Abstract][Full Text] [Related]
15. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer. Shain SA Mol Urol; 2001; 5(3):121-30. PubMed ID: 11690559 [TBL] [Abstract][Full Text] [Related]
16. Androgenic biomarker prof|ling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometry. Wilton JH; Titus MA; Efstathiou E; Fetterly GJ; Mohler JL Prostate; 2014 May; 74(7):722-31. PubMed ID: 24847527 [TBL] [Abstract][Full Text] [Related]
17. Regulation of growth hormone receptors in human prostate cancer cell lines. Bidosee M; Karry R; Weiss-Messer E; Barkey RJ Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305 [TBL] [Abstract][Full Text] [Related]
18. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
19. Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy. Shibata Y; Suzuki K; Arai S; Miyoshi Y; Umemoto S; Masumori N; Kamiya N; Ichikawa T; Kitagawa Y; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Kubota Y Andrology; 2013 May; 1(3):505-11. PubMed ID: 23444052 [TBL] [Abstract][Full Text] [Related]
20. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]